Skip to main content
OpenTrials
Completed

NCT Number: NCT04811781

Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study

The study aims to retrospectively collect epidemiological and clinical data in patients with solid tumors and SARS Covid2 infections belonging to oncology centers within the Veneto Oncology Network

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Solid Tumor, Adult

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

istituto Oncologico Veneto -UOSD Melanoma, Padova, PD, Italy

Loading trial locations.

About this study

The aim of this study is to create a Veneto Oncology Network with the aim of collecting clinical and epidemiological data of cancer Patients affected by SAR- Covid-2 infection over a period of 1 year. Descriptive statistical approaches will be used to process the data.

The aim is to evaluate the development rate of severe clinical forms of infection in patients with SARS-Cov-2 and the possible association with tumour characteristics and treatment.

In addition, the results of serological tests can be compared with the outcome of the diagnostic swabs and the clinical evolution of the infection in order to obtain more information regarding the significance of specific antibody development.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • be 18 Years and older
  • cancer patients belonging to Veneto 's Oncological Network
  • Patients with SAR COV-2 infection

Exclusion criteria

  • Patients with no SAR COV2 Infection
  • Volunteers
  • No Cancer Patients

Treatment and study plan

Primary outcomes

  1. The rate of SAR-COV2 infection development in association with tumor characteristics.

    Time frame: through study completion, an average of 18 months.

Sponsors and collaborators

Lead sponsor

Istituto Oncologico Veneto IRCCS

Other

Registry information

Official study title

Epidemiological Features and Clinical Course of SARS-CoV-2 Infection in Cancer Patients Within the Veneto Oncology Network: the ROVID Study

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Mar 23, 2021
Registry last updated
Nov 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.